back
09 Mar 2022

DPI CDC annonce accord avec KELIX bio pour acquérir PHI lors d’un 2ème

https://www.dpi-llp.com/wp-content/uploads/2022/03/DPI-CDC-annonce-accord-avec-KELIX-bio-pour-acquerir-PHI-lors-dun-2eme-Final.pdf

Related articles

DPI Exits Investment in Leading Egyptian Retailer B.TECH
| 03 Oct 2022
2022: Operating Principles for Impact Management Disclosure Statement
| 30 Sep 2022
DPI CDC announce KELIX bio agreement to acquire PHI $200m second funding round
| 09 Mar 2022
See all news
Copyright © DPI 2022